Japan Post, upward revision on March 25, ordinary profit 810 billion yen, down from 760 billion yen.

Japan Post <6178> announced a revision of its financial estimates for the fiscal year ending March 2025. The ordinary profit was revised upwards from 760 billion yen to 810 billion yen. While the profit estimates for the five postal banks <7182> and Japan Post Insurance <7181> will be revised upwards in November 2024 due to improved operating conditions and increased Asset Management revenue, the consolidated financial estimates for the full year are uncertain, particularly regarding the impact on future profits and losses from the upcoming postal rate revision at its consolidated subsidiary, Japan Post.

Fisco JapanApr 28 05:16

Wakamoto Pharmaceutical: Notice regarding revisions to earnings forecasts

JPXApr 25 15:00 · Announcements

Wakamoto Pharmaceutical To Go Ex-Dividend On March 28th, 2025 With 3 JPY Dividend Per Share

March 26th (Japan Standard Time) - $Wakamoto Pharmaceutical(4512.JP)$ is trading ex-dividend on March 28th, 2025.Shareholders of record on March 31st, 2025 will receive 3 JPY dividend per share. The

Futu NewsMar 26 05:20

Wakamoto Pharmaceutical: Notice regarding revisions to dividend forecasts

JPXMar 25 11:30 · Announcements

Wakamoat Pharmaceutical Issues FY Dividend Plan at Y3.00

Dow JonesMar 25 11:30

Spot information on individual stocks (2)

Wakamoto <4512.T> has reached its highest price since last year. A large shareholding report submitted on the 27th revealed that British investment fund Asset Value Investors holds 6.14% of the company's Stocks. Amekaze <5616.T> surged rapidly. In collaboration with Kofu City in Yamanashi Prefecture, a market event has been held. Furabedd <7840.T> remains stable. An announcement was made about the cancellation of 3.65 million shares (which is 9.50% of the total issued Stocks). Japan Post Bank <7182.T> is soft. Japan Post <6178.T> is selling Stocks.

Kabushiki ShimbunFeb 28 15:40